← All Sponsors
SPONSOR

Exelixis

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Hepatic ImpairmentModerate Hepatic Impairment
NCT06962332 Phase 1
Recruiting

Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)

Hepatic Impairment
United States View Trial →